Article

Joint effects of dietary vitamin D and sun exposure on breast cancer risk: results from the French E3N cohort.

Inserm, CESP Centre for Research in Epidemiology and Population Health, U1018, Nutrition, Hormones and Women's Health Team, F-94805, Villejuif, France.
Cancer Epidemiology Biomarkers & Prevention (Impact Factor: 4.32). 01/2011; 20(1):187-98. DOI: 10.1158/1055-9965.EPI-10-1039
Source: PubMed

ABSTRACT Ecological studies have suggested that vitamin D production through ultraviolet (UV) solar irradiance could reduce breast cancer (BC) risk. Although studies restricted to dietary vitamin D intake have provided inconsistent results, little is known about the relationship between pre- and postmenopausal BC and combined intakes from diet, supplements, and sun exposure.
Cox proportional hazards regression models evaluated the association between vitamin D intakes, mean daily ultraviolet radiation dose (UVRd) at the place of residence and risk of BC among 67,721 women of the French E3N cohort. All analyses were stratified on menopausal status taking into account important confounders including calcium consumption.
During 10 years of follow-up, a total of 2,871 BC cases were diagnosed. Dietary and supplemental vitamin D intakes were not associated with BC risk; however, in regions with the highest UVRd, postmenopausal women with high dietary or supplemental vitamin D intake had a significantly lower BC risk as compared with women with the lowest vitamin D intake (HR = 0.68, 95% CI: 0.54-0.85, and HR = 0.57, 95% CI: 0.36-0.90, respectively).
Our results suggest that a threshold of vitamin D exposure from both sun and diet is required to prevent BC and this threshold is particularly difficult to reach in postmenopausal women at northern latitudes where quality of sunlight is too poor for adequate vitamin D production.
Prospective studies should further investigate associations between BC risk, vitamin D status and sunlight exposure.

Download full-text

Full-text

Available from: Pierre Engel, Jul 03, 2015
1 Follower
 · 
128 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Epidemiologic evidence suggests a negative relation between sunlight exposure and breast cancer risk. The hypothesized mechanism is sunlight-induced cutaneous synthesis of vitamin D. To examine sun exposure and its interaction with vitamin D receptor (VDR) gene variants on breast cancer risk. We examined sun exposure and breast cancer incidence among 31,021 private pesticide applicators' wives, including 578 cases, enrolled in the prospective Agricultural Health Study cohort and followed 8.6 years on average. We estimated interactions between sun exposure, VDR variants, and breast cancer in a nested case-control study comprising 293 cases and 586 matched controls. Information on sun exposure was obtained by questionnaire at cohort enrollment. Relative risks were estimated using Cox proportional hazards regression for the cohort data and conditional logistic regression for the nested case-control data. A small decrease in breast cancer risk was observed in association with usual sun exposure ≥ 1 hour per day (versus < 1 hour per day) ten years before the start of follow-up among all participants (HR = 0.8; 95% CI: 0.6, 1.0). The association appeared slightly stronger in relation to estrogen receptor-positive tumors (HR = 0.7; 95% CI: 0.5, 0.9) than estrogen receptor-negative tumors (HR = 1.1; 95% CI: 0.6, 2.1). The HR for joint exposure ≥ 1 hour per day of sunlight and one VDR haplotype was less than expected given negative HRs for each individual exposure (interaction p-value = 0.07). These results suggest that sun exposure may be associated with reduced risk of breast cancer, but we did not find clear evidence of modification by VDR variants. Larger studies are warranted, particularly among populations in which low levels of usual sun exposure can be more precisely characterized.
    Environmental Health Perspectives 11/2013; 122(2). DOI:10.1289/ehp.1206274 · 7.03 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: France has unexplained large latitudinal variations in cancer incidence and mortality rates. Studies of cancer rate variations in several other countries, as well as in multicountry studies, have explained such variations primarily in terms of gradients in solar ultraviolet-B (UVB) doses and vitamin D production. To investigate this possibility in France, I obtained data on cancer incidence and mortality rates for 21 continental regions and used this information in regression analyses with respect to latitude. This study also used dietary data. Significant positive correlations with latitude emerged for breast, colorectal, esophageal (males), lung (males), prostate, both uterine cervix and uterine corpus, all and all less lung cancer. Although correlations with latitude were similar for males and females, the regression variance for all and all less lung cancer was about twice as high for males than for females. Lung cancer incidence and mortality rates for females had little latitudinal gradient, indicating that smoking may have also contributed to the latitudinal gradients for males. On the basis of the available dietary factor, micro- and macronutrient data, dietary differences do not significantly affect geographical variation in cancer rates. These results are consistent with solar UVB's reducing the risk of cancer through production of vitamin D. In the context of serum 25-hydroxyvitamin D level-cancer incidence relations, cancer rates could be reduced significantly in France if everyone obtained an additional 1,000 IU/day of vitamin D. Many other benefits of vitamin D exist as well.
    04/2010; 2(2):62-7. DOI:10.4161/derm.2.2.13624
  • [Show abstract] [Hide abstract]
    ABSTRACT: The vitamin D system has been strongly conserved in evolution. It links sun exposure to a multitude of endocrine messages. In most body cells the active hormone calcitriol binds intracellularly to the vitamin D receptor and regulates the expression of specific gene products. Vitamin D deficiency is epidemic affecting some 1 billion people worldwide and is mainly caused by chronically inadequate sun exposure. This deficiency is associated with harmful effects on almost all tissues including a predisposition to cancer. In cancer patients vitamin D deficiency is associated with a worsening of the prognosis. The active hormone calcitriol has anti-tumor activity and is being investigated as an anticancer agent. There is general agreement that exposure to sunlight should be increased while carefully avoiding UV erythema. In addition, recent suggestions call for a health-promoting dietary intake of 25-100 mg (1,000-4,000 IU) of vitamin D3. While supplements of vitamin D improve musculoskeletal symptoms, proof is still lacking that these doses convey a protection from cancer. Interventional studies that administer vitamin D versus placebo in patients with cancer should be a high priority because of the hypothesized benefits and the low risk of supplementation with vitamin D.
    Forschende Komplementärmedizin / Research in Complementary Medicine 01/2011; 18(4):176-84. DOI:10.1159/000330725 · 1.65 Impact Factor